SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 156 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2022$177,000
-76.4%
11,940
-57.1%
0.00%
-80.0%
Q1 2022$751,000
-38.8%
27,841
-16.0%
0.02%
-53.1%
Q4 2021$1,227,000
+50.2%
33,141
+93.8%
0.03%
+113.3%
Q3 2021$817,000
+41.1%
17,1010.0%0.02%
+36.4%
Q2 2021$579,00017,1010.01%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q3 2021
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 456,390$5,541,0003.62%
DAFNA Capital Management LLC 173,914$1,890,0000.65%
One68 Global Capital, LLC 19,861$216,0000.47%
Diametric Capital, LP 51,982$565,0000.41%
ARK Investment Management 1,383,756$15,041,0000.38%
EAM Investors, LLC 52,833$574,0000.13%
HIGHLINE CAPITAL MANAGEMENT, L.P. 31,404$341,0000.05%
Nikko Asset Management Americas, Inc. 280,548$3,050,0000.05%
MGO ONE SEVEN LLC 14,900$161,0000.04%
Qube Research & Technologies Ltd 67,702$736,0000.02%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders